Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OrbiMed
Biotech
Curevo clinches $110M, nabs Moncef Slaoui to lead board
The biotech wants to take on Shingrix with an assist from GSK vet and Operation Warp Speed chief scientific advisor Moncef Slaoui, Ph.D.
Gabrielle Masson
Mar 17, 2025 10:44am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Dec 19, 2024 6:58am
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
